T. Rowe Price Associates’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.3M | Sell |
2,464,146
-1,451,805
| -37% | -$28.9M | 0.01% | 785 |
|
|
2025
Q4 | $64.7M | Sell |
3,915,951
-652,417
| -14% | -$11M | 0.01% | 730 |
|
|
2025
Q3 | $66.3M | Sell |
4,568,368
-2,013,927
| -31% | -$28.9M | 0.01% | 713 |
|
|
2025
Q2 | $92.1M | Buy |
6,582,295
+2,215,061
| +51% | +$31.2M | 0.01% | 585 |
|
|
2025
Q1 | $59.4M | Buy |
4,367,234
+1,308,619
| +43% | +$25.1M | 0.01% | 670 |
|
|
2024
Q4 | $62.3M | Buy |
3,058,615
+188,820
| +7% | +$4.83M | 0.01% | 688 |
|
|
2024
Q3 | $83.6M | Buy |
2,869,795
+614,325
| +27% | +$15.2M | 0.01% | 605 |
|
|
2024
Q2 | $52.4M | Buy |
2,255,470
+661,137
| +41% | +$12.7M | 0.01% | 711 |
|
|
2024
Q1 | $32.7M | Sell |
1,594,333
-979,988
| -38% | -$18.4M | ﹤0.01% | 834 |
|
|
2023
Q4 | $55.2M | Sell |
2,574,321
-317,629
| -11% | -$6.29M | 0.01% | 682 |
|
|
2023
Q3 | $59.7M | Sell |
2,891,950
-553,362
| -16% | -$14M | 0.01% | 636 |
|
|
2023
Q2 | $102M | Sell |
3,445,312
-92,466
| -3% | -$2.6M | 0.01% | 522 |
|
|
2023
Q1 | $81.5M | Sell |
3,537,778
-111,110
| -3% | -$3.06M | 0.01% | 557 |
|
|
2022
Q4 | $101M | Buy |
3,648,888
+170,520
| +5% | +$5.07M | 0.02% | 488 |
|
|
2022
Q3 | $107M | Sell |
3,478,368
-1,131,809
| -25% | -$36.8M | 0.02% | 474 |
|
|
2022
Q2 | $136M | Sell |
4,610,177
-313,248
| -6% | -$8.21M | 0.02% | 578 |
|
|
2022
Q1 | $158M | Buy |
4,923,425
+287,992
| +6% | +$9.91M | 0.02% | 599 |
|
|
2021
Q4 | $207M | Sell |
4,635,433
-122,532
| -3% | -$5.81M | 0.02% | 545 |
|
|
2021
Q3 | $240M | Sell |
4,757,965
-145,487
| -3% | -$8.2M | 0.02% | 484 |
|
|
2021
Q2 | $385M | Sell |
4,903,452
-1,154,827
| -19% | -$71.4M | 0.04% | 394 |
|
|
2021
Q1 | $346M | Sell |
6,058,279
-406,547
| -6% | -$27.2M | 0.03% | 407 |
|
|
2020
Q4 | $541M | Buy |
6,464,826
+2,103,851
| +48% | +$127M | 0.06% | 308 |
|
|
2020
Q3 | $156M | Buy |
4,360,975
+1,738,813
| +66% | +$52.4M | 0.02% | 542 |
|
|
2020
Q2 | $63.4M | Buy |
2,622,162
+1,411,123
| +117% | +$33.2M | 0.01% | 771 |
|
|
2020
Q1 | $21.2M | Buy |
1,211,039
+793,883
| +190% | +$16.6M | ﹤0.01% | 1054 |
|
|
2019
Q4 | $7.27M | Sell |
417,156
-23,041
| -5% | -$384K | ﹤0.01% | 1356 |
|
|
2019
Q3 | $6.74M | Sell |
440,197
-40,943
| -9% | -$782K | ﹤0.01% | 1345 |
|
|
2019
Q2 | $9.99M | Sell |
481,140
-202
| -0% | -$4.53K | ﹤0.01% | 1317 |
|
|
2019
Q1 | $11.2M | Buy |
481,342
+4,100
| +0.9% | +$85.8K | ﹤0.01% | 1303 |
|
|
2018
Q4 | $9.86M | Buy |
477,242
+1,175
| +0.2% | +$21.3K | ﹤0.01% | 1306 |
|
|
2018
Q3 | $10.3M | Buy |
476,067
+112,242
| +31% | +$1.86M | ﹤0.01% | 1364 |
|
|
2018
Q2 | $5.55M | Sell |
363,825
-7,981
| -2% | -$150K | ﹤0.01% | 1426 |
|
|
2018
Q1 | $7.32M | Buy |
+371,806
| New | +$7.64M | ﹤0.01% | 1378 |
|
Other funds holding DNLI
VCM
VPM
